AI has learned the ins and outs of proteins. Gene editing gives scientists control of life’s molecular machinery. Together they could lead to a revolution in biotechnology.
Academic rigor, journalistic flair
Articles on CRISPR
Displaying 1 - 20 of 120 articles
Champions of xenotransplantation see it as the solution to organ shortages across the world. But this technology has other applications.
Many people know someone with a genetic disease, but few understand how gene mutations work.
Drug development takes a great deal of time, money and effort. While future profits play a big factor in which diseases gets prioritized, advocacy and research incentives can also tilt the scale.
Science is getting closer to finding a cure for HIV.
The pandemic spurred the diagnostics industry to consider aspects like scale, affordability, speed and portability of tests.
At the Third International Summit on Human Genome Editing, experts gather to discuss the path forward for CRISPR and other gene-editing technologies
Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Scientific and public uproar resulted when the Chinese scientist announced the births of the first human babies with heritable edits to their genes. A new documentary reexamines the saga.
The negative health effects of Y chromosome loss could be one potential reason women tend to live longer than men.
As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.
New developments in organ transplants from animals show promise. However, there has been no public engagement about a potential risk. It may streamline a pathway to humans for new zoonotic diseases.
The rapid rate of species declines means we should trial potential solutions before it’s too late.
Hox genes make sure all your body parts grow in the right place. Understanding how they work can reveal the process of evolution and lead to potential treatments for congenital birth defects.
Field trials of genetically edited crop plants are to be allowed in England under new government proposals.
Catherine Price, sociologist, and Nicola Patron, synthetic plant biologist, discuss the promises, dangers and concerns around gene edited and GM crops.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Researchers have grown the first human-monkey hybrid embryos as well as mouse embryos in artificial wombs late into development. These biomedical breakthroughs raise different ethical quandaries.
RNA was used to make COVID vaccines. Now it could lead to more personalised healthcare.
Top contributors
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Associate professor, Queensland University of Technology
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Professor of Chemistry, Connecticut College
-
Doctoral Student in Biochemistry, University of Washington
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Research fellow, The University of Queensland
-
Director of Research and Professor of Pathology, Dalhousie University
-
Emeritus Professor of Developmental Biology, The University of Queensland
-
Research fellow, The University of Queensland
-
Postdoctoral Associate in Science and Society, Duke University
-
Postdoctoral fellow, Harvard University
